EGFR Mutation Test
Global EGFR Mutation Test Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2025
Report ID: BMRC 2413 | Number of pages: 199 | Publish Date: Jan 2020 | Category: Lifesciences and HealthcareEGFR Mutation Test Market unveils a succinct analysis of the market size, regional spectrum and revenue forecast about the EGFR Mutation Test market. Furthermore, the report points out major challenges and latest growth plans embraced by key manufacturers that constitute the competitive spectrum of this business domain.
Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.
Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for EGFR Mutation Test. This report studies the global market size of EGFR Mutation Test, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the EGFR Mutation Test production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott
Merck
Thermo Fisher Scientific
Illumina
BioMerieux
QIAGEN
Agilent Technologies
Hologic
Novartis
Roche
Genomic Health
Market Segment by Product Type
DNA Sequencing
Kits
Market Segment by Application
Cancer Hospitals
Clinical Research Institutes
In this study, the years considered to estimate the market size of EGFR Mutation Test are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025The analysis provides an exhaustive investigation of the global EGFR Mutation Test market together with the future projections to assess the investment feasibility. Furthermore, the report includes both quantitative and qualitative analyses of the EGFR Mutation Test market throughout the forecast period. The report also comprehends business opportunities and scope for expansion. Besides this, it provides insights into market threats or barriers and the impact of regulatory framework to give an executive-level blueprint the EGFR Mutation Test market. This is done with an aim of helping companies in strategizing their decisions in a better way and finally attains their business goals.
The study objectives are:
To analyze and research the EGFR Mutation Test status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key EGFR Mutation Test manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Content Chapter 1 Global EGFR Mutation Test Market: Summary and Quantitative Analysis 1.1 Report Description 1.2 Global EGFR Mutation Test Market Revenue Overview 1.3 Global EGFR Mutation Test Market Revenue (USD Billion) and Growth (%) Rate, 2015- 2025 Chapter 2 Global EGFR Mutation Test Market: Overview and Qualitative Analysis 2.1 Executive Summary 2.2 Market Drivers 2.3 Market Restraints 2.4 Market Opportunities 2.5 Market Trends 2.6 Global EGFR Mutation Test Market: SWOT Analysis 2.7 Global EGFR Mutation Test Market: PEST Analysis 2.7 Global EGFR Mutation Test Market: Porter’s Five Forces Analysis 2.8 Global EGFR Mutation Test Market: Attractiveness Analysis 2.8.1 Global EGFR Mutation Test Market: Attractiveness Analysis by Type 2.8.2 Global EGFR Mutation Test Market: Attractiveness Analysis by Grade 2.8.3 Global EGFR Mutation Test Market: Attractiveness Analysis by Regional Chapter 3 Competitive Analysis 3.1 Global EGFR Mutation Test Market 3.1.1 Global EGFR Mutation Test market Revenue (USD Billion), By Players 2018 3.1.2 Global EGFR Mutation Test Market Revenue Share (%), By Players 2018 Chapter 5 Global EGFR Mutation Test Market: By Product Type 5.1 Global EGFR Mutation Test Market Share (%), By Product Type, 2018 5.2 Global EGFR Mutation Test Market Revenue (USD Billion), By Product Type, 2015 – 2025 5.3 Global EGFR Mutation Test Market Revenue (USD Billion), By Retro,2015-2025 5.4 Global EGFR Mutation Test Market Revenue (USD Billion), By Standing/Self-Balancing, 2015-2025 5.4 Global EGFR Mutation Test Market Revenue (USD Billion), By Folding, 2015-2025 5.5 Global EGFR Mutation Test Market Revenue Share (%), By Product Type, 2015 – 2025 5.6 Global EGFR Mutation Test Market Revenue Market Share (%), By Product Type, 2015-2025 Chapter 6 Global EGFR Mutation Test Market: By Product Type 6.1 Global EGFR Mutation Test Market Share (%), By Product Type, 2018 6.2 Global EGFR Mutation Test Market Revenue (USD Billion), By Type, 2015 – 2025 Chapter 7 North America EGFR Mutation Test Market Analysis 7.1 North America Market Snapshot 7.1.1 North America EGFR Mutation Test Market Revenue and Growth Rate (%), 2015-2025. 7.1.2 North America EGFR Mutation Test Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 7.1.3 North America EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 7.1.5 North America EGFR Mutation Test Revenue (USD Billion) Overview, By Product Type, 2015-2025 7.1.6 North America EGFR Mutation Test Revenue (USD Billion) Overview, By Product Type , 2015-2025 Chapter 8 Europe EGFR Mutation Test Market Analysis 8.1 Europe Market Snapshot 8.1.1 Europe EGFR Mutation Test Market Revenue and Growth Rate (%), 2015-2025. 8.1.2 Europe EGFR Mutation Test Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 8.1.3 Europe EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 8.1.5 Europe EGFR Mutation Test Revenue (USD Billion) Overview, By Product Type, 2015-2025 8.1.6 Europe EGFR Mutation Test Revenue (USD Billion) Overview, By Type, 2015-2025 Chapter 9 Asia Pacific EGFR Mutation Test Market Analysis 9.1 Asia Pacific Market Snapshot 9.1.1 Asia Pacific EGFR Mutation Test Market Revenue and Growth Rate (%), 2015-2025. 9.1.2 Asia Pacific EGFR Mutation Test Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 9.1.3 Asia Pacific EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 9.1.5 Asia Pacific EGFR Mutation Test Revenue (USD Billion) Overview, By Product Type, 2015-2025 9.1.6 Asia Pacific EGFR Mutation Test Revenue (USD Billion) Overview, By Type, 2015-2025 Chapter 10 Latin America EGFR Mutation Test Market Analysis 10.1 Latin America Market Snapshot 10.1.1 Latin America EGFR Mutation Test Market Revenue and Growth Rate (%), 2015-2025. 10.1.2 Latin America EGFR Mutation Test Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 10.1.3 Latin America EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 10.1.5 Latin America EGFR Mutation Test Revenue (USD Billion) Overview, By Product Type, 2015-2025 10.1.6 Latin America EGFR Mutation Test Revenue (USD Billion) Overview, By Type, 2015-2025 Chapter 11 Middle East & Africa EGFR Mutation Test Market Analysis 11.1 Middle East & Africa Market Snapshot 11.1.1 Middle East & Africa EGFR Mutation Test Market Revenue and Growth Rate (%), 2015-2025. 11.1.2 Middle East & Africa EGFR Mutation Test Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 11.1.3 Middle East & Africa EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 11.1.5 Middle East & Africa EGFR Mutation Test Revenue (USD Billion) Overview, By Product Type, 2015-2025 11.1.6 Middle East & Africa EGFR Mutation Test Revenue (USD Billion) Overview, By Type, 2015-2025 Chapter 12 Competitive Analysis 12.1 Company 1. 12.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 12.1.2 Company 1. Total Company Revenue 2015-2018 12.1.3 Company 1. Total Company Revenue, By Segment of Business 2015-2018 12.1.4 Company 1. Total Company Revenue, By Region 2015-2018 12.1.5 Company 1. Global EGFR Mutation Test Product Category and Description 12.1.6 Company 1. Recent Activity 2015-2019 12.1.7 Main Business/Business Overview 12.1.8 Business Strategy 12.1.9 SWOT Analysis 12.2 Company 2. 12.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 12.2.2 Company 2. Total Company Revenue 2015-2018 12.2.3 Company 2. Total Company Revenue, By Segment of Business 2015-2018 12.2.4 Company 2. Total Company Revenue, By Region 2015-2018 12.2.5 Company 2. Global EGFR Mutation Test Product Category and Description 12.2.6 Company 2. Recent Activity 2015-2019 12.2.7 Main Business/Business Overview 12.2.8 Business Strategy 12.2.9 SWOT Analysis 12.3 Company 3 12.3.1 Business Overview 12.3.2 Company 3Market Product Category and Description & Specification 12.3.3 Main Business/Business Overview 12.3.4 Business Strategy 12.3.5 SWOT Analysis 12.4 Company 4. 12.4.1 Business Overview 12.4.2 Company 4.Company Total Company Revenue 2015-2018 12.4.3 Company 4.Company Total Company Revenue, By Segment of Business 2015-2018 12.4.4 Company 4.Company Total Company Revenue, By Region of Business 2015-2018 12.4.5 Company 4.Company Product Category, Specification and Description 12.4.6 Company 4.Company Recent Mergers & Acquisitions (M&A) Activity 2015-2019 12.4.7 Company 4.Company Main Business/Business Overview 12.4.8 Business Strategy 12.4.9 SWOT Analysis 12.5 Company 5 12.5.1 Business Overview 12.5.2 Company 5 Company Net Sales 2015-2018 12.5.3 Company 5 Company Net Sales, By Segment of Business 2011-2018 12.5.4 Company 5 Company Net Sales, By Region 2015-2018 12.5.5 Company 5 EGFR Mutation Test Market Product Category and Specification 12.5.6 Company 5 Recent Mergers & Acquisitions (M&A) Activity 2015-2019 12.5.7 Company 5 Main Business/Business Overview 12.5.8 Business Strategy 12.5.9 SWOT Analysis 12.6 Company 6 12.6.1 Business Overview 12.6.2 Company 6 EGFR Mutation Test Market Product Category and Specification 12.6.3 Company 6 Recent Mergers & Acquisitions (M&A) Activity 2015-2019 12.6.4 Company 6 Main Business/Business Overview 12.6.5 Business Strategy 12.6.6 SWOT Analysis Chapter 13 Market Research Findings & Conclusion Chapter 14 Research Methodology 14.1 Research Process 14.2 Primary Research 14.3 Secondary Research 14.4 Market Size Estimates 14.5 Forecast Model 14.7 Who is This Report For? 14.8 USP’s of Report List of Figures FIG. 1 Global EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015- 2025 FIG. 4 Global EGFR Mutation Test Market: Attractiveness Analysis By Product Type FIG. 5 Global EGFR Mutation Test Market: Attractiveness Analysis By Type FIG. 6 Global EGFR Mutation Test Market: Attractiveness Analysis by Regional FIG. 7 Global EGFR Mutation Test Market FIG. 8 Global EGFR Mutation Test Market Share (%), By Product Type, 2018 FIG. 9 Global EGFR Mutation Test Market Revenue (USD Billion), By Application, 2015-2025 FIG. 10 Global EGFR Mutation Test Market Revenue (USD Billion), By End Use , 2015-2025 FIG. 10 Global EGFR Mutation Test Market Revenue (USD Billion), By Type, 2015-2025 FIG. 11 Global EGFR Mutation Test Market Revenue Market Share (%), By Product Type, 2015-2025 FIG. 20 North America EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. FIG. 21 North America EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. FIG. 22 Europe EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. FIG. 23 Europe EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. FIG. 24 Asia Pacific EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. FIG. 25 Asia Pacific EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. FIG. 26 Latin America EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. FIG. 27 Latin America EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. FIG. 28 Middle East & Africa EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. FIG. 29 Middle East & Africa EGFR Mutation Test Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. FIG. 30 Company 1. Total Company Revenue 2015-2018 (USD Million, R & D Expenses %) FIG. 31 Company 1. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) FIG. 32 Company 1. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %) FIG. 33 Company 2. Total Company Revenue 2015-2018 (USD Million) FIG. 34 Company 2. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) FIG. 35 Company 2. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %) 119 FIG. 36 Company 3 Total Company Revenue 2015-2018 (USD Million) FIG. 37 Company 3 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) FIG. 38 Company 3 Total Company Revenue, by Region of Business 2015-2018 (USD Million, AGR %) FIG. 39 Company 4. Company Net Sales 2015-2018 (USD Million, R & D Expenses %) FIG. 40 Company 4. Company Net Sales, by Segment of Business 2015-2018 (USD Million, AGR %) FIG. 41 Company 4. Company Net Sales, by Region 2015-2018 (USD Million, AGR %) FIG. 42 Company 5 Total Company Revenue 2015-2018 (USD Million, R & D Expenses %) FIG. 43 Company 5 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) FIG. 44 Primary Research FIG. 45 Sources of Secondary Research FIG. 46 Forecast Model List of Tables TABLE 1 Global EGFR Mutation Test Market Overview TABLE 2 Market Driver Impact Analysis TABLE 3 Market Restraints Impact Analysis TABLE 4 Global EGFR Mutation Test market Revenue (USD Billion), By Players2018 TABLE 5 Global EGFR Mutation Test market Revenue Market share (%), By Players- 2018 TABLE 6 Global EGFR Mutation Test Market Revenue (USD Billion), By Product Type, 2015 - 2025 TABLE 7 Global EGFR Mutation Test Market Revenue Share (%), By Product Type, 2015 - 2025 TABLE 8 Global EGFR Mutation Test Market Revenue (USD Billion), By Product Type, 2015 - 2025 TABLE 9 Global EGFR Mutation Test Market Revenue Share (%), By Product Type, 2015 - 2025 TABLE 10 Global EGFR Mutation Test Market Revenue (USD Billion), 2015 - 2025 TABLE 11 Global EGFR Mutation Test Market Revenue Share (%), By , 2015 - 2025 More …………...